Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I in rats

Kazutaka Higaki, Yukihiro Matsumoto, Rika Fujimoto, Yuji Kurosaki, Toshikiro Kimura

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I (rhIGF-I) were investigated after i.v. administration to rats aged 4 and 7 weeks, as young growing rats and adult rats, respectively. rhIGF-I in the plasma declined multi-exponentially in both groups of rats. Plasma concentrations of rhIGF-I were lower at almost all the time points examined in 4 weeks old rats than 7 weeks old rats. The values of total body clearance (CL(total)) and mean residence time (MRT) indicated that rhIGF-I disappeared more rapidly in 4 weeks old rats than 7 weeks old rats at any dosage. Dose-dependent pharmacokinetics was observed in 7 weeks old rats: the higher the dosage was, the larger the value of CL(total) came to be, but not in 4 weeks old rats. The amounts of IGF-binding proteins (IGFBPs) in the plasma were assessed by determining the endogenous IGF-I, and the levels of the 150 kDa complex, a ternary complex of IGF-I with IGFPB-3 and an acid labile-subunit, were found to be lower in 4 weeks old rats than in 7 weeks old rats. In rats at 4 weeks of age, the elimination of rhIGF-I was significantly faster than for the 7 week old rats, which would be due to the lower plasma levels of IGFBP-3 in young growing rats.

Original languageEnglish
Pages (from-to)115-124
Number of pages10
JournalResearch Communications in Molecular Pathology and Pharmacology
Volume97
Issue number2
Publication statusPublished - Aug 1997

Fingerprint

Insulin-Like Growth Factor I
Pharmacokinetics
Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor Binding Protein 3

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pathology and Forensic Medicine

Cite this

Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I in rats. / Higaki, Kazutaka; Matsumoto, Yukihiro; Fujimoto, Rika; Kurosaki, Yuji; Kimura, Toshikiro.

In: Research Communications in Molecular Pathology and Pharmacology, Vol. 97, No. 2, 08.1997, p. 115-124.

Research output: Contribution to journalArticle

@article{0d068fa7a2154628b7e611bd29d46a46,
title = "Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I in rats",
abstract = "Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I (rhIGF-I) were investigated after i.v. administration to rats aged 4 and 7 weeks, as young growing rats and adult rats, respectively. rhIGF-I in the plasma declined multi-exponentially in both groups of rats. Plasma concentrations of rhIGF-I were lower at almost all the time points examined in 4 weeks old rats than 7 weeks old rats. The values of total body clearance (CL(total)) and mean residence time (MRT) indicated that rhIGF-I disappeared more rapidly in 4 weeks old rats than 7 weeks old rats at any dosage. Dose-dependent pharmacokinetics was observed in 7 weeks old rats: the higher the dosage was, the larger the value of CL(total) came to be, but not in 4 weeks old rats. The amounts of IGF-binding proteins (IGFBPs) in the plasma were assessed by determining the endogenous IGF-I, and the levels of the 150 kDa complex, a ternary complex of IGF-I with IGFPB-3 and an acid labile-subunit, were found to be lower in 4 weeks old rats than in 7 weeks old rats. In rats at 4 weeks of age, the elimination of rhIGF-I was significantly faster than for the 7 week old rats, which would be due to the lower plasma levels of IGFBP-3 in young growing rats.",
author = "Kazutaka Higaki and Yukihiro Matsumoto and Rika Fujimoto and Yuji Kurosaki and Toshikiro Kimura",
year = "1997",
month = "8",
language = "English",
volume = "97",
pages = "115--124",
journal = "Research Communications in Molecular Pathology and Pharmacology",
issn = "1078-0297",
publisher = "PJD Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I in rats

AU - Higaki, Kazutaka

AU - Matsumoto, Yukihiro

AU - Fujimoto, Rika

AU - Kurosaki, Yuji

AU - Kimura, Toshikiro

PY - 1997/8

Y1 - 1997/8

N2 - Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I (rhIGF-I) were investigated after i.v. administration to rats aged 4 and 7 weeks, as young growing rats and adult rats, respectively. rhIGF-I in the plasma declined multi-exponentially in both groups of rats. Plasma concentrations of rhIGF-I were lower at almost all the time points examined in 4 weeks old rats than 7 weeks old rats. The values of total body clearance (CL(total)) and mean residence time (MRT) indicated that rhIGF-I disappeared more rapidly in 4 weeks old rats than 7 weeks old rats at any dosage. Dose-dependent pharmacokinetics was observed in 7 weeks old rats: the higher the dosage was, the larger the value of CL(total) came to be, but not in 4 weeks old rats. The amounts of IGF-binding proteins (IGFBPs) in the plasma were assessed by determining the endogenous IGF-I, and the levels of the 150 kDa complex, a ternary complex of IGF-I with IGFPB-3 and an acid labile-subunit, were found to be lower in 4 weeks old rats than in 7 weeks old rats. In rats at 4 weeks of age, the elimination of rhIGF-I was significantly faster than for the 7 week old rats, which would be due to the lower plasma levels of IGFBP-3 in young growing rats.

AB - Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I (rhIGF-I) were investigated after i.v. administration to rats aged 4 and 7 weeks, as young growing rats and adult rats, respectively. rhIGF-I in the plasma declined multi-exponentially in both groups of rats. Plasma concentrations of rhIGF-I were lower at almost all the time points examined in 4 weeks old rats than 7 weeks old rats. The values of total body clearance (CL(total)) and mean residence time (MRT) indicated that rhIGF-I disappeared more rapidly in 4 weeks old rats than 7 weeks old rats at any dosage. Dose-dependent pharmacokinetics was observed in 7 weeks old rats: the higher the dosage was, the larger the value of CL(total) came to be, but not in 4 weeks old rats. The amounts of IGF-binding proteins (IGFBPs) in the plasma were assessed by determining the endogenous IGF-I, and the levels of the 150 kDa complex, a ternary complex of IGF-I with IGFPB-3 and an acid labile-subunit, were found to be lower in 4 weeks old rats than in 7 weeks old rats. In rats at 4 weeks of age, the elimination of rhIGF-I was significantly faster than for the 7 week old rats, which would be due to the lower plasma levels of IGFBP-3 in young growing rats.

UR - http://www.scopus.com/inward/record.url?scp=0030921708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030921708&partnerID=8YFLogxK

M3 - Article

C2 - 9344224

AN - SCOPUS:0030921708

VL - 97

SP - 115

EP - 124

JO - Research Communications in Molecular Pathology and Pharmacology

JF - Research Communications in Molecular Pathology and Pharmacology

SN - 1078-0297

IS - 2

ER -